-
-
-
-
-
-
-
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
-
-
-
-
-
-
-
Korro Bio (KRRO) Misses Q3 EPS by 226c
-
-
-
-
-
-
-
Korro Bio (KRRO) Reports Q1, Appoints Kemi Olugemo as Chief Medical Officer
-
-
1,197,562 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

